Collectively, these data demonstrate that histone methyltransferase DOT1L is a novel epigenetic driver in pulmonary fibrosis, while blockade of DOT1L effectively decreases the pulmonary fibrosis phenotypes. Here, DOT1L is linked to pulmonary fibrosis.